scholarly journals Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Rena Okawa ◽  
Kazuma Kokomoto ◽  
Kazuhiko Nakano

Abstract Background Hypophosphatasia (HPP), a skeletal disease characterized by hypomineralization of bone and teeth, is caused by an ALPL gene mutation that leads to low activity of the tissue non-specific alkaline phosphatase enzyme. Although enzyme replacement therapy (ERT) was recently introduced for affected patients, no known studies have been reported regarding its dental effects related to permanent teeth and jaw bones. In the present study, we examined the dental effects of ERT in a case of childhood-type hypophosphatasia, including panoramic radiography findings used to estimate the dental age of permanent teeth and mandibular bone density. Furthermore, the effects of that therapy on the periodontal condition of the patient were evaluated by comparing periodontal pocket depth before and after initiation. Case presentation An 11-year-1-month-old boy was referred to our clinic for consultation regarding oral management. Two primary incisors had spontaneously exfoliated at 1 year 8 months old and he had been diagnosed with childhood-type HPP at the age of 2 years 2 months. Obvious symptoms were localized in the dental region at the time of diagnosis, though later extended to other parts of the body such as bone pain. ERT was started at 11 years 7 months of age, after which bone pain disappeared, and motor functions and activities of daily living improved. We estimated dental age based on tooth development stage. The age gap between chronological and dental ages was expanded before treatment, and then showed a constant decrease after ERT initiation and finally disappeared. The index for mandibular bone density (mandibular cortical width / length from mesial buccal cusp to apex of first molar) was increased after ERT initiation. Furthermore, the periodontal condition for all teeth except those exfoliated was stable after starting therapy. Conclusions ERT resulted in improved tooth and mandibular bone mineralization, with notably good effects on teeth under formation. Acceleration of mineralization of roots associated with erupting teeth leads to stabilization of the periodontal condition. We concluded that ERT contributed to the improved dental condition seen in this patient.

2002 ◽  
Vol 28 (2) ◽  
pp. 288-296 ◽  
Author(s):  
Raphael Schiffmann ◽  
Henry Mankin ◽  
James M Dambrosia ◽  
Ramnik J Xavier ◽  
Constance Kreps ◽  
...  

2019 ◽  
Vol 126 (2) ◽  
pp. S84
Author(s):  
Virginia Kimonis ◽  
Mahima Avanti ◽  
Yanjun Chen ◽  
Margaret Knight ◽  
Tahseen Mozaffar

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 3825-3825
Author(s):  
Gregory Grabowski ◽  
Joel Charrow ◽  
Neal J. Weinreb ◽  
Brian Dulisse

Abstract Bone crises and bone pain are major causes of morbidity in type 1 Gaucher disease (GD), patients. Enzyme replacement therapy (ERT) for GD has proven to be of clinical benefit in resolving hematologic abnormalities and organomegaly. However, the clinical effects of ERT on bone crisis and bone pain have not been fully evaluated. This paper reports the results of the first retrospective data analysis undertaken to examine the association between ERT in this population and the reduction of bone crisis and bone pain. Data were analyzed from the International Collaborative Gaucher Group Registry, established in 1991 as a longitudinal database to track the clinical outcomes of patients with GD, irrespective of treatment status. Inclusion criteria were GD type 1, treatment by ERT, and data available on the occurrence of bone crises and/or bone pain for 1 year prior to and for each of the 3 years following the initiation of ERT. A bone crisis was defined as pain with acute onset requiring immobilization, narcotics for pain, and periosteal elevation, leucocytosis, fever or debilitation. For bone crises and bone pain, 219 and 244 patients, respectively, met the criteria. TYPE 1 GAUCHER DISEASE PATIENTS WITH BONE CRISES AND BONE PAIN 1 YEAR PRE- AND 1, 2 AND 3 YEARS POST-ERT The numbers of patients with reports of bone crises and bone pain in each of the time periods are presented in the table. Bone crisis frequency, at 17% prior to ERT, declined to 5% or less in each of the 3 years following the initiation of ERT (t-test, p <0.0001). Similarly, bone pain, reported in 49% of patients prior to ERT, declined to approximately 30% in each of the 3 years following the initiation of ERT (t-test, p <0.0001) Yr from ERT initial infusion −1 YEAR 1 YEAR 2 YEARS 3 YEARS *n refers to number of patients Bone crisis n = 219(100%) 38(17%) 10(5%) 1(0%) 6(3%) Bone pain n = 244(100%) 119(49%) 74(30%) 71(29%) 73(30%) These results provide strong clinical evidence for ERT’s effectiveness in the reduction of bone crises and bone pain in type 1 GD.


2005 ◽  
Vol 36 (02) ◽  
Author(s):  
M Smitka ◽  
M von der Hagen ◽  
A Kaindl ◽  
C Gilitzer ◽  
J Dumontier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document